Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure
暂无分享,去创建一个
K. Anstrom | E. Braunwald | Adrian F. Hernandez | G. Lewis | M. Semigran | R. Malhotra | M. Givertz | M. Shah | G. Lewis
[1] T. Hagve,et al. [Anemia of chronic disease]. , 2017, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[2] G. Lewis,et al. Repletion of Iron Stores With the Use of Oral Iron Supplementation in Patients With Systolic Heart Failure. , 2015, Journal of cardiac failure.
[3] P. Ponikowski,et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency† , 2014, European heart journal.
[4] P. Ponikowski,et al. Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure. , 2014, European heart journal.
[5] A. Cohen-Solal,et al. High prevalence of iron deficiency in patients with acute decompensated heart failure , 2014, European journal of heart failure.
[6] G. Filippatos,et al. Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role , 2014, European journal of heart failure.
[7] P. Ponikowski,et al. Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study. , 2014, International journal of cardiology.
[8] T. Yoshiura,et al. Quantification of myocardial iron deficiency in nonischemic heart failure by cardiac T2* magnetic resonance imaging. , 2014, The American journal of cardiology.
[9] L. Rohde,et al. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. , 2013, International journal of cardiology.
[10] G. Lewis,et al. Prolonged Mean Vo2 Response Time in Systolic Heart Failure: An Indicator of Impaired Right Ventricular-Pulmonary Vascular Function , 2013, Circulation. Heart failure.
[11] P. Ponikowski,et al. Iron deficiency in chronic heart failure: an international pooled analysis. , 2013, American heart journal.
[12] Akshay S. Desai,et al. Treatment of anemia with darbepoetin alfa in systolic heart failure. , 2013, The New England journal of medicine.
[13] M. Schleinitz,et al. Outcomes of patients with chronic heart failure and iron deficiency treated with intravenous iron: a meta-analysis. , 2013, Cardiovascular & hematological disorders drug targets.
[14] James D. Thomas,et al. Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure. , 2012, Journal of the American College of Cardiology.
[15] Luc Vanhees,et al. Clinical Recommendations for Cardiopulmonary Exercise Testing Data Assessment in Specific Patient Populations , 2012, Circulation.
[16] Jeroen J. Bax,et al. Global Longitudinal Strain Predicts Long-Term Survival in Patients With Chronic Ischemic Cardiomyopathy , 2012, Circulation. Cardiovascular imaging.
[17] L. Leibovici,et al. Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta‐analysis , 2012, European journal of heart failure.
[18] G. Bailie. Comparison of rates of reported adverse events associated with i.v. iron products in the United States. , 2012, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[19] A. Elhendy,et al. Tissue Doppler and Strain Rate Imaging Detect Improvement of Myocardial Function in Iron Deficient Patients with Congestive Heart Failure after Iron Replacement Therapy , 2012, Echocardiography.
[20] E. Tay,et al. Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome. , 2011, International journal of cardiology.
[21] C. D. dos Remedios,et al. Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure. , 2011, Journal of the American College of Cardiology.
[22] Ross Arena,et al. Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. , 2010, Circulation.
[23] P. Ponikowski,et al. Molecular changes in myocardium in the course of anemia or iron deficiency. , 2010, Heart failure clinics.
[24] P. Ponikowski,et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. , 2009, The New England journal of medicine.
[25] K. Dickstein,et al. Six-Minute Walk Test and Cardiopulmonary Exercise Testing in Patients With Chronic Heart Failure: A Comparative Analysis on Clinical and Prognostic Insights , 2009, Circulation. Heart failure.
[26] P. Ponikowski,et al. Rationale and design of Ferinject® Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia , 2009, European journal of heart failure.
[27] G. Weiss. Iron metabolism in the anemia of chronic disease. , 2009, Biochimica et biophysica acta.
[28] R. I. Usmanov,et al. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. , 2008, Journal of nephrology.
[29] P. Ponikowski,et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. , 2007, Journal of the American College of Cardiology.
[30] J. Dungan. Intravenous Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Postpartum Anemia: A Randomized Controlled Trial , 2008 .
[31] P. Duarte,et al. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. , 2007, Journal of the American College of Cardiology.
[32] A. Mangione,et al. Intravenous Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Postpartum Anemia: A Randomized Controlled Trial , 2007, Obstetrics and gynecology.
[33] M. Gulati,et al. Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing. , 2007, Circulation.
[34] D. Richardson,et al. Iron uptake and metabolism in the new millennium. , 2007, Trends in cell biology.
[35] D. Karageorgopoulos,et al. Etiology of anemia in patients with advanced heart failure. , 2006, Journal of the American College of Cardiology.
[36] A. Bolger,et al. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. , 2006, Journal of the American College of Cardiology.
[37] Jun Ren,et al. Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration. , 2005, Clinical science.
[38] M. Lauer,et al. Peak Oxygen Consumption as a Predictor of Death in Patients With Heart Failure Receiving β-Blockers , 2005, Circulation.
[39] L. Pinai,et al. EXERCISE AND HEART FAILURE: A STATEMENT FROM THE AMERICAN HEART ASSOCIATION COMMITTEE ON EXERCISE, REHABILITATION, AND PREVENTION , 2003 .
[40] I. Piña,et al. Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. , 2003, Circulation.
[41] W. Hundley,et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. , 2002, JAMA.
[42] J. Haas,et al. Iron-Deficiency Anemia: Reexamining the Nature and Magnitude of the Public Health Problem Iron Deficiency and Reduced Work Capacity: A Critical Review of the Research to Determine a Causal Relationship 1,2 , 2001 .
[43] A. Coats,et al. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). , 2000, European heart journal.
[44] P. Ponikowski,et al. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). , 2000, European heart journal.
[45] P. Ponikowski,et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. , 1997, Journal of the American College of Cardiology.
[46] Z. Georgieva,et al. Compensatory and adaptive changes in microcirculation and left ventricular function of patients with chronic iron-deficiency anaemia. , 1997, Clinical hemorheology and microcirculation.
[47] P. Poole‐Wilson,et al. Exercise limitation in chronic heart failure: central role of the periphery. , 1996, Journal of the American College of Cardiology.
[48] J. A. Speer,et al. Comparison of polysaccharide iron complexes used as iron supplements. , 1995, Journal of inorganic biochemistry.
[49] D. Petering,et al. Iron deficiency in growing male rats: a cause of development of cardiomyopathy. , 1990, Annals of nutrition & metabolism.
[50] F. Cobb,et al. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. , 1990, Circulation.
[51] P. Dallman. Iron deficiency: does it matter? , 1989, Journal of internal medicine.
[52] S. Frostick,et al. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. , 1988, Circulation.
[53] H. Drexler,et al. Blood flow distribution within skeletal muscle during exercise in the presence of chronic heart failure: effect of milrinone. , 1987, Circulation.
[54] V. Herbert. Recommended dietary intakes (RDI) of iron in humans. , 1987, The American journal of clinical nutrition.
[55] B. Massie,et al. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. , 1985, The American journal of cardiology.
[56] G. Brooks,et al. Distinguishing effects of anemia and muscle iron deficiency on exercise bioenergetics in the rat. , 1984, The American journal of physiology.
[57] F. M. Bennett. A role for neural pathways in exercise hyperpnea. , 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.
[58] G. Brooks,et al. Muscle mitochondrial bioenergetics, oxygen supply, and work capacity during dietary iron deficiency and repletion. , 1982, The American journal of physiology.
[59] K. Davies,et al. Effects of dietary iron deficiency of iron-sulfur proteins and bioenergetic functions of skeletal muscle mitochondria. , 1982, Biochimica et biophysica acta.
[60] V. Edgerton,et al. Work Capacity, Heart Rate and Blood Lactate Responses to Iron Treatment , 1979, British journal of haematology.
[61] Ganzoni Am,et al. [Intravenous iron-dextran: therapeutic and experimental possibilities]. , 1970, Schweizerische medizinische Wochenschrift.
[62] A. Ganzoni. [Intravenous iron-dextran: therapeutic and experimental possibilities]. , 1970, Schweizerische medizinische Wochenschrift.